Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AT&T Impresses With Subscriber Growth and Free Cash Flow


Coming a few days after a mixed earnings report from rival Verizon Communications, AT's (NYSE: T) second-quarter report suffered from a similar problem. Wireless customers have been slow to upgrade their smartphones, leading to lower equipment revenue for the wireless leaders.

AT saw equipment revenue drop 5.8% year over year in the second quarter, enough to cause the company to miss analyst expectations. But unlike Verizon, which saw its stock drop in the wake of its earnings report, AT stock had one of its best days in months on Wednesday.

The sluggishness of customers upgrading their phones does reduce AT's revenue, but it doesn't turn a profit on equipment sales. Discounted and subsidized smartphones are a component of the company's customer acquisition strategy.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

€0.056
-0.890%
The price for the Allergy Therapeutics PLC stock decreased slightly today. Compared to yesterday there is a change of -€0.001 (-0.890%).

Like: 0
T
Share

Comments